Sleep Cycle AB (publ) (SLEEP) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

based AI already trust by millions nightly to enable non-invasive smartphone based apnea screening. No wearables, no cables, no clinic visits, AI powered screening using only the iPhone microphone. Affordable and accessible for underserved populations. So medical grade precision, but consumer grade simplicity. It's a natural extension of our platform and it's aligned with our mission to improve global health. And importantly, it reflects the shift toward proactive personalized health care, enabling earlier detection at that scale. So sleep apnea obviously represents a strategic leap for sleep cycle. It significantly expands our total addressable market, and it creates a new high margin revenue stream, both through in-app B2C purchases and emerging B2B opportunities. We're basically stepping into preventive health, aligning with a global shift towards proactive at-home care. The home testing market alone is already around one billion US dollar and growing. So there is a massive unmet medical need, and we are making screening more accessible and tech-driven. This move position us not just as a sleep app in the future, but also a health platform for the future. So to validate our solution ahead of our FDA application, we are right now running a clinical study led by two of our foremost experts. This study is conducted in Australia with 700 participants. In parallel, we're getting ready for everything that needs to be in order before submitting to FDA. And after that, of course, also to CE for being able to sell this in the European markets. But now let's look at our cue to performance. So I hand over to Elizabeth. Thank you, Erik. Now let's look at our financial development for the second quarter. The number of paying subscribers decreased by 2.2% year over year, landin...